Notice of Results & Investor Presentation
EKF Diagnostics Holdings plc will announce its unaudited interim results for the six months ended 30 June 2026 on Tuesday 15 September, and will host a live online investor presentation on the same day at 4:30pm BST via the Investor Meet Company platform. The presentation will also be available on the company's website, with a recording to follow on the Investor Meet Company platform.
Select text to share a quote on X · sign in to keep highlights & notes in your EKF notes
EKF Diagnostics Holdings plc (AIM: EKF), the AIM-quoted global diagnostics business, will announce its unaudited interim results for the six months ended 30 June 2026 on Tuesday 15 September.
Investor presentation
EKF Diagnostics will be hosting a live online presentation open to all existing and potential investors on Tuesday 15 September 2026 at 4.30pm (BST) via the Investor Meet Company platform.
Investors can sign up to Investor Meet Company for free and add to meet EKF Diagnostics via:
The investor presentation will be available on the Company's website at www.ekfdiagnostics.com and a recording of the presentation and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.
| EKF Diagnostics Holdings plc | www.ekfdiagnostics.com |
| Gavin Jones, Chief Executive Officer | via Walbrook PR |
| Helen Jones, Chief Financial Officer | |
| Singer Capital Markets (Nominated Adviser & Broker) | |
| Jen Boorer / Russell Cook / Patrick Weaver | Tel: +44 (0)20 7496 3000 |
| Walbrook PR Limited | Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com |
| Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0) 7407 804 654 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.